Philip Jon Rosenthal MD
Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
1001 Potrero AvenueBldg 30 4th FloorSan Francisco, CA 94110
Phone+1 415-206-5438
Fax+1 415-648-8425
Are you Dr. Rosenthal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Philip Rosenthal, MD is an infectious disease specialist in San Francisco, California. He is currently licensed to practice medicine in California and Michigan. He is a Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 1985 - 1988
University of MichiganResidency, Internal Medicine, 1982 - 1985
New York University School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1985 - 2026
MI State Medical License 1982 - 1988
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine During Malaria Chemoprevention in Pregnant Women.Norah Mwebaza, Michelle E Roh, Yourong Z Geng, Leonard Opio, Bishop Opira
Clinical Pharmacology and Therapeutics. 2025-02-01 - 2 citationsThe 2024 Public Health Emergency of International Concern: A Global Failure to Control Mpox.Alimuddin Zumla, Philip J Rosenthal, Nada A Sam-Agudu, Dimie Ogoina, Placide Mbala-Kingebeni
The American Journal of Tropical Medicine and Hygiene. 2025-01-08 - Joel G. Breman, ASTMH Past President (1936-2024).Richard W Steketee, Philip J Rosenthal
The American Journal of Tropical Medicine and Hygiene. 2025-01-08
Press Mentions
2015 AST FAST DesigneesMay 21st, 2015
Grant Support
- Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipelineUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2028
- Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in UgandaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Pharmacological insights into antimalarial exposure, clinical outcomes, and drug resistance in AfricaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2015–2025
- Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in UgandaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2025
